Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Oncoplastic breast surgery does not delay the onset of adjuvant chemotherapy: a population-based study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. A systematic review of observational studies of trifluridine/tipiracil (TAS-102) for metastatic colorectal cancer

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Publishing your trial protocols with Acta Oncologica; your contribution to scientific transparency

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. European cancer rehabilitation and survivorship, 2018: one of a kind

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Clinical, Physiologic, and Behavioral Evaluation of Permanently Catheterized NMRI Mice

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Pattern of mortality after menopausal hormone therapy: long-term follow up in a population-based cohort

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Evaluation of tumor-infiltrating lymphocytes and association with prognosis in BRCA-mutated breast cancer

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Nonaspirin NSAIDs and contralateral breast cancer risk

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

BACKGROUND: Only a few studies of limited size have examined whether oncoplastic breast surgery delays the onset of adjuvant chemotherapy as compared to conventional breast surgery. We investigated whether oncoplastic breast surgery causes a delay in the onset of adjuvant chemotherapy in comparison to lumpectomy and mastectomy.

MATERIAL AND METHODS: The study is a population-based cohort study. Within the nationwide registry of the Danish Breast Cancer Group (DBCG), we identified 1798 patients who received adjuvant chemotherapy following mastectomy, lumpectomy or oncoplastic breast surgery for early and unilateral invasive breast cancer. Women treated with neoadjuvant chemotherapy were excluded.

RESULTS: We found no significant difference between the three groups (mastectomy, lumpectomy, oncoplastic breast surgery) in the time from biopsy to surgery (mean time 17.9, 17.0 and 18.3 days, respectively), the time from surgery to onset of adjuvant chemotherapy, nor total time from biopsy to the onset of adjuvant chemotherapy (mean time 52.7, 51.9 and 53.2 days, respectively).

CONCLUSIONS: Our study shows that oncoplastic breast surgery does not delay the onset of adjuvant chemotherapy in comparison with mastectomy and lumpectomy. Accordingly, patients should not be excluded from treatment with oncoplastic breast surgery due to concerns of delay in adjuvant chemotherapy.

OriginalsprogEngelsk
TidsskriftActa oncologica (Stockholm, Sweden)
Vol/bind56
Udgave nummer5
Sider (fra-til)719-723
Antal sider5
ISSN0284-186X
DOI
StatusUdgivet - maj 2017

ID: 52152458